Abstract
In the global movement to enhance transparency in financial relationships between physicians and the healthcare industry, almost all payments from pharmaceutical and medical device companies to physicians in the United States have been publicly disclosed in the Open Payments Database since 2013.1 Allergists and clinical immunologists are experts who received one of the largest per-physician general payments in the country in 2015.2 The coronavirus disease 2019 (COVID-19) pandemic may have limited financial interaction between the healthcare industry and these experts, but few studies have investigated the trend in industry payments related to allergology and immunology during the COVID-19 pandemic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
